LBF20107PG10: Difference between revisions

No edit summary
No edit summary
 
(15 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Lipid/Header}}
{{Hierarchy|{{PAGENAME}}}}
{{Hierarchy|{{PAGENAME}}}}


Line 4: Line 6:
|LipidBank=XPR1736
|LipidBank=XPR1736
|LipidMaps=LMFA03010054
|LipidMaps=LMFA03010054
|SysName=9-oxo-15S-hydroxy-prosto-13E-en-1-oic acid
|SysName=9-Oxo-15S-hydroxy-prosto-trans-13-en-1-oic acid
|Common Name=&&11-deoxy Prostaglandin E_1&&9-oxo-15S-hydroxy-prosto-13E-en-1-oic acid&&
|Common Name=&&11-deoxy Prostaglandin E_1&&9-Oxo-15S-hydroxy-prosto-13(E)-en-1-oic acid&&
|Source=
|Chemical Synthesis=
|Metabolism=
|Biological Activity= 11-deoxy Prostaglandin E1 shows spieces and subtype dependent EP agonistic effect. In guinea pig, 11-deoxy Prostaglandin E1 induce bronchodilation and vasodepression. [[Reference:Hall_DW:Jaitly_KD:,Prostaglandins,1976,11,573|{{RelationTable/GetFirstAuthor|Reference:Hall_DW:Jaitly_KD:,Prostaglandins,1976,11,573}}]] 11-deoxy Prostaglandin E1 is reported to increase cAMP release via EP receptors in Jurkat cells. [[Reference:De_Vries_GW:Guarino_P:McLaughlin_A:Chen_J:Andrews_S:Woodward_DF:,Br. J. Pharmacol.,1995,115,1231|{{RelationTable/GetFirstAuthor|Reference:De_Vries_GW:Guarino_P:McLaughlin_A:Chen_J:Andrews_S:Woodward_DF:,Br. J. Pharmacol.,1995,115,1231}}]] The Ki value of each murine EPs is 600 nM (EP1), 45 nM (EP2), 1.1 nM (EP3), 23 nM (EP4) .[[Reference:Kiriyama_M:Ushikubi_F:Kobayashi_T:Hirata_M:Sugimoto_Y:Narumiya_S:,Br. J. Pharmacol.,1997,122,217|{{RelationTable/GetFirstAuthor|Reference:Kiriyama_M:Ushikubi_F:Kobayashi_T:Hirata_M:Sugimoto_Y:Narumiya_S:,Br. J. Pharmacol.,1997,122,217}}]] 11-deoxy Prostaglandin E1, a selective EP2/EP3/EP4 agonist, inhibites IL-1beta-induced IL-6 production in human gingival fibroblast.[[Reference:Noguchi_K:Shitashige_M:Endo_H:Kondo_H:Ishikawa_I:,J. Periodont. Res.,2002,37,29|{{RelationTable/GetFirstAuthor|Reference:Noguchi_K:Shitashige_M:Endo_H:Kondo_H:Ishikawa_I:,J. Periodont. Res.,2002,37,29}}]] 11-deoxy Prostaglandin E1 stimulates K secretion through EP2 receptors at EC50 values of 8.3 nM in guinea pig distal colonic mucosa .[[Reference:Halm_DR:Halm_ST:,Am. J. Physiol. Gastrointest. Liver Physiol.,2001,281,G984|{{RelationTable/GetFirstAuthor|Reference:Halm_DR:Halm_ST:,Am. J. Physiol. Gastrointest. Liver Physiol.,2001,281,G984}}]]
}}
}}
{{Lipid/Footer}}

Latest revision as of 08:07, 21 October 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



11-deoxy Prostaglandin E1
LBF20107PG10.png
Structural Information
9-Oxo-15S-hydroxy-prosto-trans-13-en-1-oic acid
  • 11-deoxy Prostaglandin E1
  • 9-Oxo-15S-hydroxy-prosto-13(E)-en-1-oic acid
Formula C20H34O4
Exact Mass 338.24570957599997
Average Mass 338.48156
SMILES C(CC[C@@H](O)C=C[C@H]([C@H]1CCCCCCC(O)=O)CCC(=O)1)CC
Physicochemical Information
11-deoxy Prostaglandin E1 shows spieces and subtype dependent EP agonistic effect. In guinea pig, 11-deoxy Prostaglandin E1 induce bronchodilation and vasodepression. Hall_DW et al. 11-deoxy Prostaglandin E1 is reported to increase cAMP release via EP receptors in Jurkat cells. De_Vries_GW et al. The Ki value of each murine EPs is 600 nM (EP1), 45 nM (EP2), 1.1 nM (EP3), 23 nM (EP4) . Kiriyama_M et al. 11-deoxy Prostaglandin E1, a selective EP2/EP3/EP4 agonist, inhibites IL-1beta-induced IL-6 production in human gingival fibroblast. Noguchi_K et al. 11-deoxy Prostaglandin E1 stimulates K secretion through EP2 receptors at EC50 values of 8.3 nM in guinea pig distal colonic mucosa . Halm_DR et al.
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20107PG10 See above. De_Vries_GW et al. 1995
n.a. LBF20107PG10 See above. Hall_DW et al. 1976
n.a. LBF20107PG10 See above. Halm_DR et al. 2001
n.a. LBF20107PG10 See above. Kiriyama_M et al. 1997
n.a. LBF20107PG10 See above. Noguchi_K et al. 2002